Development and evaluation of lipid microbubbles targeted to alpha(v)beta(3)-integrin via biotinavidin bridge

Journal of Microencapsulation

Volumn 29, Issue 2, 2012, Pages 177-184

  Wang, Wei ^a   Liu, Guang Jian ^a   Xie, Xiao Yan ^a   Xu, Zuo Feng ^a   Chen, Li Da ^a   Huang, Guang Liang ^a   Zhou, Lu Yao ^a   Lu, Ming De ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

angiogenesis; contrast enhanced ultrasound; molecular imaging; phospholipids; targeted microbubbles; tumour targeting

Indexed keywords

AVIDIN; BIOTIN; SULFUR HEXAFLUORIDE; VITRONECTIN RECEPTOR;

ARTICLE; CELL ADHESION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBUBBLE; MOLECULAR IMAGING; PROTEIN TARGETING; QUALITY CONTROL; ULTRASOUND; UMBILICAL VEIN ENDOTHELIAL CELL;

AVIDIN; BIOTIN; CELLS, CULTURED; CONTRAST MEDIA; ENDOTHELIAL CELLS; HUMANS; IMAGE ENHANCEMENT; INTEGRIN ALPHAVBETA3; MICROBUBBLES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84863184003     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.638993     Document Type: Article

References (41)

1. Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology, 2006;130:8-16. (Pubitemid 43049830)
2. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. A stimulusresponsive contrast agent for ultrasound molecular imaging. Biomaterials, 2008;29:597-606. (Pubitemid 350100802)
3. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrinα vβ 3 for angiogenesis. Science, 1994;264:569-71.
4. Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci, 2007;12:5124-42.
5. Ellegala DB, Poi HL, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted toα vβ (3). Circulation, 2003;108:336-41. (Pubitemid 36899026)
6. Guenther F, Von ZMC, Ferrante EA, Grundmann S, Bode C, Klibanov AL. An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol, 2010;45:586-91.
7. Huang SL. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev, 2008;60:1167-76.
8. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ, Lindner JR. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation, 2007;116:276-84. (Pubitemid 47196563)
9. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev, 1999;37:139-57. (Pubitemid 29164505)
10. Klibanov AL, ed. 2002. Ultrasound contrast agents: Development of the field and current status. In: Contrast agents II. Topics in current chemistry. Berlin, Heidelberg: Springer-Verlag, pp. 73-106.
11. Klibanov AL. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem, 2005;16:9-17. (Pubitemid 40129671)
12. Klibanov AL. Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol, 2006;41:354-62. (Pubitemid 44406198)
13. Klibanov AL. Ultrasound molecular imaging with targeted microbubble contrast agents. J Nucl Cardiol, 2007;14:876-84. (Pubitemid 350082585)
14. Klibanov AL. Preparation of targeted microbubbles: Ultrasound contrast agents for molecular imaging. Med Biol Eng Comput, 2009;47:875-82.
15. Klibanov AL, Hughes MS, Marsh JN, Hall CS, Miller JG, Wible JH, Brandenburger GH. Targeting of ultrasound contrast material: An in vitro feasibility study. Acta Radiol, 1997;38:113-20. (Pubitemid 127619170)
16. Klibanov AL, Hughes MS, Wojdyla JK, Marsh JN, Hall CS, Miller JG, Wible JH, Brandenburger GH. Targeting of ultrasound contrast material: Selective imaging of microbubbles in vitro. Acad Radiol, 1998;5(Suppl 1):S243-6.
17. Klibanov AL, Rasche PT, Hughes MS, Wojdyla JK, Galen KP, Wible JH, Brandenburger GH. Detection of individual microbubbles of ultrasound contrast agents: Imaging of free-floating and targeted bubbles. Invest Radiol, 2004;39:187-95. (Pubitemid 38263925)
18. Korpanty G, Grayburn PA, Shohet RV, Brekken RA. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol, 2005;31:1279-83. (Pubitemid 41318861)
19. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation, 1996;94:3334-40. (Pubitemid 26427506)
20. Lee DJ, Lyshchik A, Huamani J, Hallahan DE, Fleischer AC. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. J Ultrasound Med, 2008;27:855-66. (Pubitemid 351913824)
21. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted toα (v)-integrins. Circulation, 2003;107:455-60. (Pubitemid 36158049)
22. Lindner JR. Microbubbles in medical imaging: Current applications and future directions. Nat Rev Drug Discov, 2004;3:527-32. (Pubitemid 38807535)
23. Lindner JR. Molecular imaging of myocardial and vascular disorders with ultrasound. JACC Cardiovasc Imaging, 2010;3:204-11.
24. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complementmediated adherence to activated leukocytes. Circulation, 2000;101:668-75. (Pubitemid 30094739)
25. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation, 2001;104:2107-12. (Pubitemid 33027054)
26. Pysz MA, Willmann JK. Targeted contrast-enhanced ultrasound: An emerging technology in abdominal and pelvic imaging. Gastroenterology, 2011;140:785-90.
27. Rossi S, Waton G, Krafft MP. Small phospholipid-coated gas bubbles can last longer than larger ones. Chem Phys Chem, 2008;9:1982-5.
28. Schumann PA, Christiansen JP, Quigley RM, Mccreery TP, Sweitzer RH, Unger EC, Lindner JR, Matsunaga TO. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol, 2002;37:587-93. (Pubitemid 35231692)
29. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. Detection of tumor angiogenesis in vivo byα vβ3-targeted magnetic resonance imaging. Nat Med, 1998;4:623-6. (Pubitemid 28237365)
30. Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER, Ferrara KW. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging, 2008;3:9-18. (Pubitemid 351493974)
31. Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release, 2004;96:473-82. (Pubitemid 38553925)
32. Villanueva FS, Jankowski RJ, Manaugh C, Wagner WR. Albumin microbubble adherence to human coronary endothelium: Implications for assessment of endothelial function using myocardial contrast echocardiography. J Am Coll Cardiol, 1997; 30:689-93. (Pubitemid 27397648)
33. Villanueva FS, Lu EX, Bowry S, Kilic S, Tom E, Wang JJ, Gretton J, Pacella JJ, Wagner WR. Myocardial ischemic memory imaging with molecular echocardiography. Circulation, 2007;115:345-52. (Pubitemid 46151660)
34. Villanueva FS, Wagner WR, Vannan MA, Narula J. Targeted ultrasound imaging using microbubbles. Cardiology Clin, 2004;22:283-98. (Pubitemid 38680772)
35. Weller GE, Villanueva FS, Klibanov AL, Wagner WR. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng, 2002;30:1012-19. (Pubitemid 35457697)
36. Weller GE, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: In vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng, 2005a;92:780-8. (Pubitemid 41772473)
37. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res, 2005b;65:533-9.
38. Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology, 2008a;248:936-44.
39. Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology, 2008b;246:508-18.
40. Willmann JK, Van BN, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat Rev Drug Discov, 2008c;7:591-607. (Pubitemid 351927724)
41. Zhao YZ, Luo YK, Zhang Y, Mei XG, Tang J. Property and contrast-enhancement effects of lipid ultrasound contrast agent: a preliminary experimental study. Ultrasound Med Biol, 2005;31:537-43.